Clinical trial
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
NCT03781817 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 9, 2019
- Completion date
- April 30, 2022
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
children, only, deep sedation, fractures, closed, ketamine, trauma